• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用贝叶斯网络和人工智能从健康人群中识别进展性 CKD:基于工作场所的队列研究。

Identifying progressive CKD from healthy population using Bayesian network and artificial intelligence: A worksite-based cohort study.

机构信息

Medical Science, Kawasaki Medical School, Okayama, Japan.

Department of Nephrology, Tokyo Medical University, Tokyo, Japan.

出版信息

Sci Rep. 2019 Mar 25;9(1):5082. doi: 10.1038/s41598-019-41663-7.

DOI:10.1038/s41598-019-41663-7
PMID:30911092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6434140/
Abstract

Identifying progressive early chronic kidney disease (CKD) patients at a health checkup is a good opportunity to improve their prognosis. However, it is difficult to identify them using common health tests. This worksite-based cohort study for 7 years in Japan (n = 7465) was conducted to evaluate the progression of CKD. The outcome was aggravation of the KDIGO prognostic category of CKD 7 years later. The subjects were male, 59.1%; age, 50.1 ± 6.3 years; and eGFR, 79 ± 14.4 mL/min/1.73 m. The number of subjects showing CKD progression started to increase from 3 years later. Vector analysis showed that CKD stage G1 A1 was more progressive than CKD stage G2 A1. Bayesian networks showed that the time-series changes in the prognostic category of CKD were related to the outcome. Support vector machines including time-series data of the prognostic category of CKD from 3 years later detected the high possibility of the outcome not only in subjects at very high risks but also in those at low risks at baseline. In conclusion, after the evaluation of kidney function at a health checkup, it is necessary to follow up not only patients at high risks but also patients at low risks at baseline for 3 years and longer.

摘要

在体检中识别进展性早期慢性肾脏病(CKD)患者是改善其预后的良好机会。然而,使用常规健康检查来识别他们是困难的。本研究对日本一个工作场所开展了为期 7 年的队列研究(n=7465),旨在评估 CKD 的进展。结局为 7 年后 KDIGO CKD 预后类别加重。受试者为男性,占 59.1%;年龄为 50.1±6.3 岁;eGFR 为 79±14.4mL/min/1.73m。出现 CKD 进展的受试者数量从 3 年后开始增加。向量分析显示 CKD 阶段 G1 A1 比 CKD 阶段 G2 A1 更具进展性。贝叶斯网络显示 CKD 预后类别的时间序列变化与结局相关。包括 3 年后 CKD 预后类别时间序列数据的支持向量机不仅可以检测出极高风险人群的结局发生的高可能性,也可以检测出基线时低风险人群的结局发生的高可能性。总之,在体检评估肾功能后,不仅需要对高风险患者,而且需要对基线时低风险患者进行 3 年及以上的随访。

相似文献

1
Identifying progressive CKD from healthy population using Bayesian network and artificial intelligence: A worksite-based cohort study.利用贝叶斯网络和人工智能从健康人群中识别进展性 CKD:基于工作场所的队列研究。
Sci Rep. 2019 Mar 25;9(1):5082. doi: 10.1038/s41598-019-41663-7.
2
Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.慢性肾脏病 4 期和 5 期患者转诊至肾脏管理门诊后的自然病程。
Int Urol Nephrol. 2009 Dec;41(4):977-82. doi: 10.1007/s11255-009-9604-3. Epub 2009 Jul 4.
3
Accounting for Age in the Definition of Chronic Kidney Disease.在慢性肾脏病的定义中考虑年龄因素。
JAMA Intern Med. 2021 Oct 1;181(10):1359-1366. doi: 10.1001/jamainternmed.2021.4813.
4
Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.新型尿液生物标志物可改善早期慢性肾脏病阶段和无慢性肾脏病高危个体中进行性 EGFR 损失的预测。
Sci Rep. 2018 Oct 29;8(1):15940. doi: 10.1038/s41598-018-34386-8.
5
Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.慢性肾脏病队列研究(CRIC):肾脏疾病结局与慢性肾脏病风险因素的相关性研究。
Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.
6
White blood cell count predicts the odds of kidney function decline in a Chinese community-based population.白细胞计数可预测中国社区人群肾功能下降的几率。
BMC Nephrol. 2017 Jun 7;18(1):190. doi: 10.1186/s12882-017-0608-4.
7
Early Coaching to Increase Water Intake in CKD.早期干预以增加慢性肾脏病患者的水分摄入。
Ann Nutr Metab. 2020;76 Suppl 1:69-70. doi: 10.1159/000515276. Epub 2021 Mar 29.
8
Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.基线肾小球滤过率降低作为新发慢性肾脏病风险因素的首要地位:一项针对日本受试者的纵向研究
Nephrology (Carlton). 2017 Sep;22(9):684-689. doi: 10.1111/nep.12836.
9
Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.肾血管性高血压患者慢性肾脏病进展的临床病理预测因素:基于肾活检的队列研究。
Nephrol Dial Transplant. 2019 Jul 1;34(7):1182-1188. doi: 10.1093/ndt/gfy121.
10
Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.早期发病 2 型糖尿病患者发生进展性慢性肾脏病的风险:一项前瞻性队列研究。
Nephrol Dial Transplant. 2020 Jan 1;35(1):115-121. doi: 10.1093/ndt/gfy211.

引用本文的文献

1
Variational quantum classifier-based early identification and classification of chronic kidney disease using sparse autoencoder and LASSO shrinkage.基于变分量子分类器,利用稀疏自编码器和套索收缩法对慢性肾脏病进行早期识别和分类
PeerJ Comput Sci. 2025 Apr 17;11:e2789. doi: 10.7717/peerj-cs.2789. eCollection 2025.
2
Development of Artificial Intelligence Systems for Chronic Kidney Disease.慢性肾脏病人工智能系统的开发
JMA J. 2025 Jan 15;8(1):48-56. doi: 10.31662/jmaj.2024-0090. Epub 2024 Sep 6.
3
Artificial Intelligence in Nephrology: Clinical Applications and Challenges.

本文引用的文献

1
Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices.慢性肾脏病临床评估指南:AMED药品和医疗器械监管科学研究
Clin Exp Nephrol. 2018 Dec;22(6):1446-1475. doi: 10.1007/s10157-018-1615-x.
2
Japanese Clinical Practice Guideline for Diabetes 2016.《2016年日本糖尿病临床实践指南》
J Diabetes Investig. 2018 Mar 26;9(3):657-97. doi: 10.1111/jdi.12810.
3
Chronic kidney disease.慢性肾脏病。
肾脏病学中的人工智能:临床应用与挑战
Kidney Med. 2024 Nov 12;7(1):100927. doi: 10.1016/j.xkme.2024.100927. eCollection 2025 Jan.
4
Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis.人工智能在预测慢性肾脏病预后中的应用。一项系统评价与Meta分析。
Ren Fail. 2024 Dec;46(2):2435483. doi: 10.1080/0886022X.2024.2435483. Epub 2024 Dec 11.
5
Predicting the Progression of Chronic Kidney Disease: A Systematic Review of Artificial Intelligence and Machine Learning Approaches.预测慢性肾脏病的进展:人工智能和机器学习方法的系统评价
Cureus. 2024 May 12;16(5):e60145. doi: 10.7759/cureus.60145. eCollection 2024 May.
6
Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning.采用机器学习预测非癌症晚期慢性肾脏病患者 3 年死亡风险的特定模式和潜在风险因素。
Medicine (Baltimore). 2024 Feb 16;103(7):e37112. doi: 10.1097/MD.0000000000037112.
7
Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms.使用人工智能算法预测新诊断2型糖尿病患者发生终末期肾病的风险。
BioData Min. 2023 Mar 10;16(1):8. doi: 10.1186/s13040-023-00324-2.
8
Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality.基于机器学习的用于预测慢性肾脏病进展和死亡率的网络系统。
PLOS Digit Health. 2023 Jan 18;2(1):e0000188. doi: 10.1371/journal.pdig.0000188. eCollection 2023 Jan.
9
Predict, diagnose, and treat chronic kidney disease with machine learning: a systematic literature review.利用机器学习预测、诊断和治疗慢性肾脏病:系统文献回顾。
J Nephrol. 2023 May;36(4):1101-1117. doi: 10.1007/s40620-023-01573-4. Epub 2023 Feb 14.
10
Identifying risk factors of developing type 2 diabetes from an adult population with initial prediabetes using a Bayesian network.利用贝叶斯网络从初诊前期糖尿病的成年人群中识别 2 型糖尿病的发病风险因素。
Front Public Health. 2023 Jan 12;10:1035025. doi: 10.3389/fpubh.2022.1035025. eCollection 2022.
Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88.
4
Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.肾小球滤过率变化作为日本普通人群终末期肾病未来发病率替代终点的重要性:基于社区的队列研究。
Clin Exp Nephrol. 2018 Apr;22(2):318-327. doi: 10.1007/s10157-017-1463-0. Epub 2017 Sep 7.
5
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.日本患者慢性肾脏病进展的危险因素:来自日本慢性肾脏病队列(CKD-JAC)研究的结果。
Clin Exp Nephrol. 2017 Jun;21(3):446-456. doi: 10.1007/s10157-016-1309-1. Epub 2016 Jul 13.
6
Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.行为修正对早中期慢性肾脏病结局的影响:一项整群随机试验
PLoS One. 2016 Mar 21;11(3):e0151422. doi: 10.1371/journal.pone.0151422. eCollection 2016.
7
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.肾小球滤过率下降作为 CKD 临床试验的终点:由美国国家肾脏基金会和美国食品药品监督管理局赞助的科学研讨会。
Am J Kidney Dis. 2014 Dec;64(6):821-35. doi: 10.1053/j.ajkd.2014.07.030. Epub 2014 Oct 16.
8
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).日本高血压学会高血压管理指南(JSH 2014)
Hypertens Res. 2014 Apr;37(4):253-390. doi: 10.1038/hr.2014.20.
9
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.KDIGO 美国评论:2012 年 KDIGO 慢性肾脏病评估与管理临床实践指南
Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16.
10
Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians.1 至 3 期慢性肾脏病的筛查、监测和治疗:美国医师学院临床实践指南。
Ann Intern Med. 2013 Dec 17;159(12):835-47. doi: 10.7326/0003-4819-159-12-201312170-00726.